ID: ALA5204642

Max Phase: Preclinical

Molecular Formula: C21H32O3

Molecular Weight: 332.48

Associated Items:

Representations

Canonical SMILES:  CC1(C)CCC[C@]2(C)[C@@H](Cc3cc(O)cc(O)c3)[C@](C)(O)CC[C@@H]12

Standard InChI:  InChI=1S/C21H32O3/c1-19(2)7-5-8-20(3)17(19)6-9-21(4,24)18(20)12-14-10-15(22)13-16(23)11-14/h10-11,13,17-18,22-24H,5-9,12H2,1-4H3/t17-,18+,20-,21+/m0/s1

Standard InChI Key:  QXFSMKJNJYLPQH-IZZBFERCSA-N

Associated Targets(non-human)

Sclerotinia sclerotiorum 877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Rhizoctonia solani 2251 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Fusarium graminearum 1554 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Pyricularia oryzae 1832 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Phytophthora capsici 336 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 332.48Molecular Weight (Monoisotopic): 332.2351AlogP: 4.63#Rotatable Bonds: 2
Polar Surface Area: 60.69Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.35CX Basic pKa: CX LogP: 4.78CX LogD: 4.78
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.74Np Likeness Score: 2.40

References

1. Wang X, Hu N, Kong W, Song B, Li S..  (2022)  Facile and divergent optimization of chromazonarol enabled the identification of simplified drimane meroterpenoids as novel pharmaceutical leads.,  227  [PMID:34653771] [10.1016/j.ejmech.2021.113912]

Source